ALT5 Sigma (ALTS) Stock Price, News & Analysis

Company Overview

ALT5 Sigma Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments. The Biotechnology segment focuses on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. The Recycling segment is involved in a turnkey appliance recycling program. The company was founded by Edward R. Cameron in 1976 and is headquartered in Las Vegas, NV.

Key Stats

• Today's Range: $8.05 to $9.04
• 50-Day Range: $6.03 to $10.26
• 52-Week Range: $1.38 to $10.95
• Volume: 570,076 shs
• Average Volume: 245,062 shs
• Market Capitalization: $180.66 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ALTS Stock Analysis - Frequently Asked Questions

How have ALTS shares performed this year?

ALT5 Sigma's stock was trading at $4.65 on January 1st, 2025. Since then, ALTS shares have increased by 92.9% and is now trading at $8.97.

Who are ALT5 Sigma's major shareholders?

ALT5 Sigma's top institutional investors include Geode Capital Management LLC (0.97%), Evernest Financial Advisors LLC (0.07%), Simplex Trading LLC and Belvedere Trading LLC. Insiders that own company stock include Peter Tassiopoulos and Virland A Johnson.
View institutional ownership trends.

How do I buy shares of ALT5 Sigma?

Shares of ALTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of ALT5 Sigma own?

Based on aggregate information from My MarketBeat watchlists, some other companies that ALT5 Sigma investors own include JIADE (JDZG), Hyzon Motors (HYZN), New Horizon Aircraft (HOVR), Hour Loop (HOUR), Gossamer Bio (GOSS), Genius Group (GNS) and Ford Motor (F).

Company Calendar

• Today: 8/08/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Finance
• Industry: FIN - MISC SVCS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:ALTS
• Previous Symbol: NASDAQ:ALTS
• CIK: 862861
• Web: N/A
• Phone: (702) 997-5968
• Fax: 952-930-1800
• Employees: 170
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$6.24 million
• Net Margins: -38.58%
• Pretax Margin: -53.44%
• Return on Equity: -113.79%
• Return on Assets: -8.96%

Debt

• Debt-to-Equity Ratio: 1.26
• Current Ratio: 0.83
• Quick Ratio: 0.83

Sales & Book Value

• Annual Sales: $12.53 million
• Price / Sales: 14.42
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.49 per share
• Price / Book: 18.31

Miscellaneous

• Outstanding Shares: 20,140,000
• Free Float: 19,156,000
• Market Cap: $180.66 million
• Optionable: N/A
• Beta: 2.17